Gewinn- und Verlustrechnung von CMS Energy Corporation

JACKSON, Mich., Oct. 6, 2026 /PRNewswire/ -- CMS Energy announced today it will provide 2026 third quarter results along with a business and financial outlook at 10:00 a.m.

Peter Thiel has scored some big wins as a tech investor and company founder, but that doesn't mean everything he touches will turn to gold.

CMS Energy Corporation (NYSE: CMS - Get Free Report)'s stock price reached a new 52-week low during trading on Tuesday. The stock traded as low as $62.29 and last traded at $62.9570, with a volume of 164696 shares. The stock had previously closed at $62.60. Analyst Upgrades and Downgrades Several research firms recently issued reports on

Labcorp shares dropped sharply after CMS released preliminary 2027 lab-payment rates, aligning Medicare rates closer to private insurers and targeting $1B annual savings. I see the selloff as overdone, with market fears exaggerated by a misunderstanding of the CMS report's impact on LH's bottom line. The proposed cuts only affect Medicare's Clinical Laboratory Fee Schedule, with annual reimbursement reductions capped at 15% and final rates pending.

CMS Energy Corporation (NYSE: CMS - Get Free Report) hit a new 52-week low during trading on Wednesday. The company traded as low as $64.19 and last traded at $64.2480, with a volume of 4446236 shares changing hands. The stock had previously closed at $64.70. Wall Street Analysts Forecast Growth Several equities analysts recently weighed

Shares of CMS Energy Corporation (NYSE: CMS - Get Free Report) reached a new 52-week low during trading on Thursday. The stock traded as low as $65.67 and last traded at $65.9950, with a volume of 2050103 shares. The stock had previously closed at $65.92. Analyst Ratings Changes Several research firms have commented on CMS.

Corient Private Wealth LP reduced its stake in CMS Energy Corporation (NYSE: CMS) by 5.5% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 147,623 shares of the utilities provider's stock after selling 8,599 shares during the quarter. Corient Private Wealth LP's holdings

CMS Energy remains positioned to become a Dividend Aristocrat early next decade. The regulated utility topped the analyst consensus for both operating revenue and adjusted EPS in the second quarter. CMS Energy possesses a BBB S&P credit rating with a stable outlook.

Nykredit A S bought a new stake in CMS Energy Corporation (NYSE: CMS) in the undefined quarter, according to its most recent disclosure with the SEC. The fund bought 17,941 shares of the utilities provider's stock, valued at approximately $1,372,000. A number of other institutional investors and hedge funds also recently bought and

SHENZHEN, CHINA, Sept. 03, 2026 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited (“CMS” or the “Group”) is pleased to announce that its subsidiary, Dermavon Holdings Limited (“Dermavon”, an innovative pharmaceutical company specialized in skin health which is applying for a separate listing on the Main Board of The Stock Exchange of Hong Kong Limited) received the approval from the National Medical Products Administration of China (NMPA) for the New Drug Application (NDA) of ruxolitinib phosphate cream (Lumirix®) for the treatment of mild to moderate atopic dermatitis (“AD”) on 2 September 2026. The drug registration certificate was obtained on 3 September 2026. The product is indicated for the topical short-term and non-continuous chronic treatment of mild to moderate atopic dermatitis in non-immunocompromised adult and pediatric patients 2 years of age and older whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable.